Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: poindexter an 3rd. Pain Manag. 2023 Apr;13(4):205-211. doi: 10.2217/pmt-2022-0085. Epub 2023 May 15. Pain Manag. 2023. PMID: 37183454 Review.
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: poindexter an 3rd. Obstet Gynecol. 2022 Dec 1;140(6):920-930. doi: 10.1097/AOG.0000000000004988. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357960 Free PMC article. Clinical Trial.
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: poindexter an 3rd. N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283. N Engl J Med. 2021. PMID: 33596357 Free PMC article. Clinical Trial.
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years.
Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Meric D, Dessy FJ, Datta SK, Descamps D, Dubin G; HPV-010 Study Group. Einstein MH, et al. Hum Vaccin. 2011 Dec;7(12):1343-58. doi: 10.4161/hv.7.12.18281. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22048173 Free PMC article. Clinical Trial.
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.
Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Lebacq M, van der Most R, Moris P, Giannini SL, Schuind A, Datta SK, Descamps D; HPV-010 Study Group. Einstein MH, et al. Hum Vaccin. 2011 Dec;7(12):1359-73. doi: 10.4161/hv.7.12.18282. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22048172 Free PMC article. Clinical Trial.
Paternal influences on the timing of prenatal care among Hispanics.
Sangi-Haghpeykar H, Mehta M, Posner S, Poindexter AN 3rd. Sangi-Haghpeykar H, et al. Among authors: poindexter an 3rd. Matern Child Health J. 2005 Jun;9(2):159-63. doi: 10.1007/s10995-005-3012-9. Matern Child Health J. 2005. PMID: 15965621
Condom use among sterilized and nonsterilized Hispanic women.
Sangi-Haghpeykar H, Horth F, Poindexter AN 3rd. Sangi-Haghpeykar H, et al. Among authors: poindexter an 3rd. Sex Transm Dis. 2001 Sep;28(9):546-51. doi: 10.1097/00007435-200109000-00013. Sex Transm Dis. 2001. PMID: 11518874
36 results